Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study
Authors:
- J.J. De WaeleJWJ.J. De Waele
- J.M. TelladoJTJ.M. Tellado
- J. AlderJAJ. Alder
- P. ReimnitzPRP. Reimnitz
- M. JensenMJM. Jensen
- B. HampelBHB. Hampel
- P. ArvisPAP. Arvis
Open Access
- 1 January 2013
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 41 (1) , 57-64
Abstract
No abstract availableKeywords
Funding Information
- Bayer HealthCare
This publication has 27 references indexed in Scilit:
- Essentials for Selecting Antimicrobial Therapy for Intra-Abdominal InfectionsDrugs, 2012
- Hepatic safety of antibiotics used in primary careJournal of Antimicrobial Chemotherapy, 2011
- Epidemiologic Trends, Occurrence of Extended-Spectrum β-Lactamase Production, and Performance of Ertapenem and Comparators in Patients with Intra-Abdominal Infections: Analysis of Global Trend Data from 2002–2007 from the SMART StudySurgical Infections, 2010
- Safety Profile of the Respiratory Fluoroquinolone MoxifloxacinDrug Safety, 2009
- What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?Journal of Antimicrobial Chemotherapy, 2008
- Antimicrobial treatment for intra-abdominal infectionsExpert Opinion on Pharmacotherapy, 2007
- National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004Antimicrobial Agents and Chemotherapy, 2007
- Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin???Tazobactam and Amoxicillin???Clavulanate for the Treatment of Complicated Intra-abdominal InfectionsAnnals of Surgery, 2006
- Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitisJournal of Antimicrobial Chemotherapy, 2006
- In Vitro Activity of Moxifloxacin against 923 Anaerobes Isolated from Human Intra-Abdominal InfectionsAntimicrobial Agents and Chemotherapy, 2006